Rebiopsy in patients with untreated hepatitis C: a useful procedure

Journal of Clinical Gastroenterology
Sandra Tuma KhouriMaria Lucia G Ferraz

Abstract

The progression of fibrosis in the early stages of chronic hepatitis C virus is variable, and the ideal interval to perform a new biopsy in untreated patients is still unknown. We evaluated the histologic progression of patients with untreated hepatitis C virus with two liver biopsies and correlated disease progression with demographic, epidemiologic, biochemical, and histologic variables. Untreated hepatitis C virus-infected patients with two liver biopsies at a minimum interval of 1 year were studied. Gender, age, parenteral risk factors, duration of infection, alcohol intake, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyltransferase, and histologic findings were analyzed. Fifty-five patients were included. The first biopsy showed low grades of fibrosis and periportal necroinflammatory activity in 93%. A second biopsy was performed after 39 +/- 14 months; 40% of patients showed a progression of fibrosis and/or periportal necroinflammation. Comparison between groups with and without histologic worsening revealed no differences in demographic, epidemiologic, biochemical, or histologic data. Histologic worsening occurred in 40% of untreated patients after 3.2 years. No factor could be established at the fir...Continue Reading

References

Jun 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·V J DesmetP J Scheuer
May 1, 1993·Seminars in Liver Disease·S W FrenchC L Mendenhall
Jul 1, 1993·Gastroenterology·J Ludwig
Jun 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M YanoK Okuda
Dec 1, 1996·Journal of Clinical Pathology·V ParadisP Bedossa
Sep 26, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L B Seeff
Mar 21, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P MathurinT Poynard
Jun 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F PessioneB Rueff
Jun 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G OstapowiczP V Desmond
Sep 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T E WileyT J Layden
Mar 3, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D M Bissell
Mar 30, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L F HouriganE E Powell
Sep 25, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y BenhamouT Poynard
Mar 23, 2000·Journal of Hepatology·N Boyer, P Marcellin
Jun 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M WieseU Oesen
Jul 15, 2000·Seminars in Liver Disease·T PoynardP Opolon
Aug 18, 2000·Seminars in Liver Disease·P A Sheiner
Apr 3, 2001·Journal of Hepatology·A D CloustonE E Powell
Jun 9, 2001·European Journal of Gastroenterology & Hepatology·G Ramadori, V Meier
Jun 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fabrizio FabriziPaul Martin
Aug 8, 2002·Journal of Gastroenterology and Hepatology·Jason M HuiJacob George
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Leonard B Seeff
Jan 4, 2003·Gastroenterology·Marc G GhanyJay H Hoofnagle
Feb 15, 2003·Journal of Hepatology·Jean-Pierre ZarskiRobert Gish
Feb 19, 2003·Journal of Clinical Gastroenterology·Renuka Bhattacharya, Margaret C Shuhart
Feb 20, 2003·Journal of Hepatology·Alfredo Alberti, Luisa Benvegnù
Dec 31, 2003·Lancet·Thierry PoynardChing Lung Lai
Mar 5, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alexander MontoTeresa L Wright
Jan 5, 2005·Digestive Diseases and Sciences·Conrado M Fernández-RodriguezMaria Luisa Casas

❮ Previous
Next ❯

Citations

Dec 28, 2007·Journal of Hepatology·Hashem El-Serag, Jennifer R Kramer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Liver International : Official Journal of the International Association for the Study of the Liver
Pierre PradatChristian Trépo
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
H B El-SeragC Key
© 2022 Meta ULC. All rights reserved